AAAAAA

   
Results: 1-7 |
Results: 7
A RANDOMIZED CONTROLLED TRIAL OF ACYCLOVIR VERSUS NETIVUDINE FOR TREATMENT OF HERPES-ZOSTER
Authors: SOLTZSZOTS J TYRING S ANDERSEN PL LUCHT RF MCKENDRICK MW PEREZ JLD SHUKLA S FIDDIAN AP
Citation: J. Soltzszots et al., A RANDOMIZED CONTROLLED TRIAL OF ACYCLOVIR VERSUS NETIVUDINE FOR TREATMENT OF HERPES-ZOSTER, Journal of antimicrobial chemotherapy, 41(5), 1998, pp. 549-556
CLINICAL EFFICACY OF HIGH-DOSE ACYCLOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A METAANALYSIS OF RANDOMIZED INDIVIDUAL PATIENT DATA
Authors: IOANNIDIS JPA COLLIER AC COOPER DA COREY L FIDDIAN AP GAZZARD BG GRIFFITHS PD CONTOPOULOSIOANNIDIS DG LAU J PAVIA AT SAAG MS SPRUANCE SL YOULE MS
Citation: Jpa. Ioannidis et al., CLINICAL EFFICACY OF HIGH-DOSE ACYCLOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A METAANALYSIS OF RANDOMIZED INDIVIDUAL PATIENT DATA, The Journal of infectious diseases, 178(2), 1998, pp. 349-359
TREATMENT OF ACUTE HERPES-ZOSTER - EFFECT OF EARLY (LESS-THAN-48 H) VERSUS LATE (48-72 H) THERAPY WITH ACYCLOVIR AND VALACICLOVIR ON PROLONGED PAIN
Authors: WOOD MJ SHUKLA S FIDDIAN AP CROOKS RJ
Citation: Mj. Wood et al., TREATMENT OF ACUTE HERPES-ZOSTER - EFFECT OF EARLY (LESS-THAN-48 H) VERSUS LATE (48-72 H) THERAPY WITH ACYCLOVIR AND VALACICLOVIR ON PROLONGED PAIN, The Journal of infectious diseases, 178, 1998, pp. 81-84
ANTIVIRAL DRUGS IN DEVELOPMENT FOR HERPES-ZOSTER
Authors: FIDDIAN AP
Citation: Ap. Fiddian, ANTIVIRAL DRUGS IN DEVELOPMENT FOR HERPES-ZOSTER, Scandinavian journal of infectious diseases, 1996, pp. 51-54
VALACICLOVIR - AN IMPROVED TREATMENT FOR INDIVIDUALS WITH HIV AIDS
Authors: FIDDIAN AP
Citation: Ap. Fiddian, VALACICLOVIR - AN IMPROVED TREATMENT FOR INDIVIDUALS WITH HIV AIDS, Antiviral chemistry & chemotherapy, 6, 1995, pp. 51-53
IMPACT OF LONG-TERM ACYCLOVIR ON CYTOMEGALOVIRUS-INFECTION AND SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: PRENTICE HG GLUCKMAN E POWLES RL LJUNGMAN P MILPIED NJ RANADA JMF MANDELLI F KHO P KENNEDY L BELL AR HAMON MD COUMAR A HIRSCH I HANRAHAN A BURNETT A RUSSELL N HUNTER A CAHN JY FLESCH M FIERE D TIGAUD J ASHCAN J ARCESE W DINUCCI G GENTILE G DELAURENZI A PACILLI L ROSSIFERRINI P BOSI A MARTELLI M AVERSA F FELICINI R TURA S ROSTI G BERLARDINELLI AR BERNASCONI C ALLESSANDRINO E LUCARELLI G GALIMBERTI M KOLB JH CAMERA R BEESLEY K FIDDIAN AP GEFFRIER C PAPARATTI U PARKE A USAN L
Citation: Hg. Prentice et al., IMPACT OF LONG-TERM ACYCLOVIR ON CYTOMEGALOVIRUS-INFECTION AND SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Lancet, 343(8900), 1994, pp. 749-753
ZIDOVUDINE IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION AND CD4-THAN 400 PER CUBIC MILLIMETER( CELL COUNTS GREATER)
Authors: COOPER DA GATELL JM KROON S CLUMECK N MILLARD J GOEBEL FD BRUUN JN STINGL G MELVILLE RL GONZALEZLAHOZ J STEVENS JW FIDDIAN AP
Citation: Da. Cooper et al., ZIDOVUDINE IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION AND CD4-THAN 400 PER CUBIC MILLIMETER( CELL COUNTS GREATER), The New England journal of medicine, 329(5), 1993, pp. 297-303
Risultati: 1-7 |